...
机译:体重指数增加对B型利钠肽(BNP)和N端proBNP准确性对失代偿性心力衰竭的诊断和全因死亡率的预测的影响
Robert H. Christenson,1* Hassan M.E. Azzazy,2 Show-Hong Duh,1 Susan Maynard,3 Stephen L. Seliger,4 and Christopher R. deFilippi51 Department of Pathology, 4 Division of Nephrology, and 5 Division of Cardiology, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, 2 Department of Chemistry, The American University in Cairo, Cairo, Egypt, 3 Department of Pathology, Carolinas Medical Center, Charlotte, NC.* Address correspondence to this author at: Department of Pathology, University of Maryland School of Medicine, 22 S. Greene St., Baltimore, MD 21201. Fax 410-328-5880, e-mail rchristenson@umm.edu.Received May 5, 2009, accepted January 11, 2010.Previously published online at DOI: 10.1373/clinchem.2009.129742Author Contributions: All authors confirmed they have contributed to the intellectual content of this paper and have met the following 3 requirements: (a) significant contributions to the conception and design, acquisition of data, or analysis and interpretation of data, (b) drafting or revising the article for intellectual content, and (c) final approval of the published article.Authors' Disclosures of Potential Conflicts of Interest: Upon manuscript submission, all authors completed the Disclosures of Potential Conflict of Interest form. Potential conflicts of interest:Employment or Leadership: None declared.Consultant or Advisory Role: C.R. deFillippi, Siemens, R.H. Christenson, Siemens Diagnostics, Response Biomedical, and Radiometer.Stock Ownership: None declared.Honoraria: C.R. deFillippi, Siemens and Roche Diagnostics, R.H. Christenson, Siemens Healthcare Diagnostics, Ortho Clinical Diagnostics, and Response Biomedical.Research Funding: C.R. deFillippi, Siemens and Roche Diagnostics, S.L. Seliger, Roche, Inc., R.H. Christenson, Siemens Healthcare Diagnostics, Response Biomedical, and Radiometer.Expert Testimony: None declared.Role of Sponsor: The funding organizations played no role in the design of study, choice of enrolled patients, review and interpretation of data, or preparation or approval of manuscript.,;
机译:体重指数增加对B型利钠肽(BNP)和N端proBNP准确性的影响,用于诊断失代偿性心力衰竭和预测全因死亡率。
机译:体重指数增加对B型利钠肽(BNP)和N端proBNP准确性对失代偿性心力衰竭的诊断和全因死亡率的预测的影响
机译:体重指数对N-末端促脑钠肽和脑利钠肽的准确性的影响,以预测慢性心力衰竭患者的结果,降低范式 - HF研究中的射血分数见解(ARNI与ACEI的前瞻性比较 对全球死亡率和心力衰竭试验中发病率的影响)
机译:患有ADHF患者的死亡率预测神经网络(急性失代偿心力衰竭)
机译:接受Sacubitril / Valsartan治疗的射血分数降低的慢性心力衰竭患者急性失代偿性心力衰竭期间B型利钠肽和N端脑钠肽的演变:病例报告
机译:无心力衰竭的肥胖患者B型利钠肽(BNp)和N末端pro-BNp:与体重指数和胃旁路手术的关系